Clinical Trial of High-dose Vitamin C for Advanced Pancreatic Cancer
Status:
Terminated
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This is a phase II study. It is designed to provide information about if high-dose ascorbate
(vitamin C) increases survival for pancreatic cancer patients. The hypothesis is that vitamin
C is well tolerated and increases cancer treatment effectiveness, lengthening survival time
for patients with advanced pancreatic cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Joseph J. Cullen
Collaborators:
Holden Comprehensive Cancer Center National Cancer Institute (NCI) Susan L Bader Foundation of Hope